Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
This multi-site study will use a pre-post design with a population-based comparison group to investigate the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Comprehensive Vaccination History Review | Patients who receive a comprehensive vaccination history review at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vaccine administration by a pharmacist | Biological | Administration, number and types, of vaccines by a pharmacist |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in vaccination rates for routinely recommended adult vaccinations | Change from baseline rates | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of vaccines administered | Change from baseline rates | 6 months |
| Types of vaccines administered | Change from baseline rates | 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults eligible to receive vaccinations for preventable diseases
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Benjamin M Bluml, BPharm | American Pharmacists Association Foundation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Walmart Pharmacy | Atlantic | Iowa | 50022 | United States | ||
| Medicap Pharmacy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Unmet vaccination needs identified and met | Behavioral | Identification of unmet vaccination needs and having those needs met |
|
| Vaccination forecast review and patient education | Behavioral | Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs |
|
| Number of unmet vaccination needs that were identified and met | Measured through study completion | 6 months |
| Carlisle |
| Iowa |
| 50047 |
| United States |
| NuCara Pharmacy | Coralville | Iowa | 52241 | United States |
| Eagle Pharmacy | Eagle Grove | Iowa | 50533 | United States |
| Medicap Pharmacy | Eldora | Iowa | 50627 | United States |
| Medicap Pharmacy | Indianola | Iowa | 50125 | United States |
| Towncrest Pharmacy | Iowa City | Iowa | 52240 | United States |
| Hy-Vee Pharmacy | Iowa City | Iowa | 52245 | United States |
| Walmart Pharmacy | Knoxville | Iowa | 50138 | United States |
| Osterhaus Pharmacy | Maquoketa | Iowa | 52060 | United States |
| Hy-Vee Pharmacy | Marion | Iowa | 52302 | United States |
| Walmart Pharmacy | Pella | Iowa | 50219 | United States |
| NuCara Pharmacy | Pleasant Hill | Iowa | 50327 | United States |
| NuCara Pharmacy | Traer | Iowa | 50675 | United States |
| Greenwood Pharmacy | Waterloo | Iowa | 50702 | United States |
| Meyer Pharmacy | Waverly | Iowa | 50677 | United States |
| Hy-Vee Pharmacy | West Des Moines | Iowa | 50265 | United States |
| NuCara Pharmacy | West Union | Iowa | 52175 | United States |
| Montross Pharmacy | Winterset | Iowa | 50273 | United States |
| Safeway Pharmacy | Bellevue | Washington | 98005 | United States |
| Safeway Pharmacy | Issaquah | Washington | 98029 | United States |
| Albertsons Sav-On Pharmacy | Redmond | Washington | 98053 | United States |
| ID | Term |
|---|---|
| D007251 | Influenza, Human |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D009976 | Orthomyxoviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019859 | Proto-Oncogene Proteins c-met |
| D010353 | Patient Education as Topic |
| ID | Term |
|---|---|
| D020794 | Receptor Protein-Tyrosine Kinases |
| D011505 | Protein-Tyrosine Kinases |
| D011494 | Protein Kinases |
| D017853 | Phosphotransferases (Alcohol Group Acceptor) |
| D010770 | Phosphotransferases |
| D014166 | Transferases |
| D004798 | Enzymes |
| D045762 | Enzymes and Coenzymes |
| D047908 | Intracellular Signaling Peptides and Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D011956 | Receptors, Cell Surface |
| D008565 | Membrane Proteins |
| D017978 | Receptors, Growth Factor |
| D018000 | Receptors, Peptide |
| D011518 | Proto-Oncogene Proteins |
| D015513 | Oncogene Proteins |
| D009363 | Neoplasm Proteins |
| D006266 | Health Education |
| D011314 | Preventive Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided